PF669 RUXOLITINIB TREATMENT AND RISK OF B‐CELL LYMPHOMAS IN MYELOPROLIFERATIVE NEOPLASMS
Cavalloni, C., Rumi, E., Zibellini, S., Boveri, E., Riboni, R., Casetti, I., Ciboddo, M., Trotti, C., Favaron, C., Pietra, D., Candido, C., Ferretti, V., Cazzola, M., Arcaini, L.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article